Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study that paves the way ...

A lung-cancer screening programme which sees a mobile unit visit communities in Warwickshire has led to hundreds of people ...

In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...

As many as half of all nursing home patients may benefit from respiratory therapy, given rising complexity and common conditions such as COPD, congestive heart failure and other chronic breathing and ...

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

Trilaciclib protects bone marrow before SCLC chemotherapy, sharply reducing neutropenia, anemia, and thrombocytopenia, improving fatigue and keeping treatment on schedule without weakening tumor kill.

A new study finds Black Medicare beneficiaries with early-stage non–small cell lung cancer (NSCLC) continues to receive curative treatment at lower rates than White patients, highlighting ongoing ...

Restoring the gut microbiota through fecal microbiota transplantation reversed these effects. The treatment replenished CX3CR1-positive NK cells, reduced lung damage, and improved survival. Targeted ...

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

Taryne A. Imai, MD, found herself at a professional crossroads in 2022. She had been working for seven years as a thoracic surgeon, most recently as Clinical Chief of Thoracic Surgery at Cedars-Sinai ...